<p>Embrace higher titers and robust yield. Our optimized, end-to-end VirusExpress<sup>®</sup> lentivirus platform delivering maximized production and quality outcomes to enable the success for your cell or gene therapy. Benefit from accelerated development timelines, de-risked manufacturing, and achieve the performance and product quality critical for clinical trials, all while delivering a lower cost per therapeutic dose.&nbsp;</p>
<p>In this webinar, you will discover how our comprehensive lentivirus platform enables clinical and commercial success by:</p>
<ul>
<li>Accelerating timelines</li>
<li>Achieving higher titers and quality per batch</li>
<li>Conserving your time and resources</li>
<li>Delivering lower cost/ therapeutic dose</li>
</ul>


aem-GridColumn aem-GridColumn--default--9

<br/><br/><h2 class="webinar-subtitle">WEBINAR</h2>

Make More Lentivirus and Make it Right the First Time

aem-GridColumn aem-GridColumn--default--9 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

aem-GridColumn aem-GridColumn--default--3 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

In this webinar, you will discover how our comprehensive lentivirus platform enables clinical and commercial success.